Barinthus Biotherapeutics plc (BRNS)
Official siteHEALTHCARE • BIOTECHNOLOGY • PINK
Market Cap: $30.23M
Last updated: Nov 13, 2026 at 4:00 PM ET
Barinthus Biotherapeutics plc (BRNS) Earnings: Report Dates and Results
Barinthus Biotherapeutics (BRNS) is expected to report earnings on Mar 11, 2027. In the quarter ended Jun 30, 2026, Barinthus Biotherapeutics reported EPS of -$0.26, above the -$0.28 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
BRNS has an expected report date of Mar 11, 2027.
Earnings History
Of the 22 quarters below that had an estimate, BRNS beat 16 and missed 6. The widest gap in the table came in the quarter ended Jun 30, 2022, when EPS landed 207.50% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.26 | -$0.28 | -$0.28 - -$0.28 | +7.14% | Beat | N/A | 1 | 0 up, 1 down | Aug 6, 2026 | N/A |
| Mar 31, 2026 | -$0.14 | -$0.28 | -$0.28 - -$0.28 | +50.00% | Beat | N/A | 1 | 0 up, 1 down | Apr 30, 2026 | N/A |
| Dec 31, 2025 | -$0.27 | -$0.39 | -$0.40 - -$0.29 | +29.82% | Beat | N/A | 2 | 1 up, 0 down | Mar 13, 2026 | N/A |
| Sep 30, 2025 | -$0.24 | -$0.39 | -$0.45 - -$0.34 | +38.46% | Beat | N/A | 2 | 0 up, 0 down | Nov 7, 2025 | N/A |
| Jun 30, 2025 | -$0.52 | -$0.29 | -$0.37 - -$0.29 | -79.31% | Miss | N/A | 2 | 1 up, 1 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$0.49 | -$0.36 | -$0.41 - -$0.30 | -36.11% | Miss | N/A | 3 | 1 up, 1 down | May 7, 2025 | N/A |
| Dec 31, 2024 | -$0.20 | -$0.37 | -$0.42 - -$0.29 | +45.38% | Beat | N/A | 3 | 1 up, 0 down | Mar 20, 2025 | N/A |
| Sep 30, 2024 | -$0.21 | -$0.44 | -$0.49 - -$0.41 | +52.27% | Beat | N/A | 3 | 0 up, 0 down | Nov 6, 2024 | $14.97M |
| Jun 30, 2024 | -$0.43 | -$0.41 | -$0.46 - -$0.38 | -4.88% | Miss | N/A | 3 | 0 up, 0 down | Aug 8, 2024 | N/A |
| Mar 31, 2024 | -$0.40 | -$0.61 | -$0.67 - -$0.35 | +34.43% | Beat | N/A | 4 | 0 up, 0 down | May 13, 2024 | N/A |
| Dec 31, 2023 | -$0.45 | -$0.50 | -$0.62 - -$0.27 | +10.00% | Beat | N/A | 5 | 0 up, 0 down | Mar 20, 2024 | $5.37M |
| Sep 30, 2023 | -$0.37 | -$0.55 | -$0.55 - -$0.50 | +32.73% | Beat | -268.2% | 3 | 0 up, 0 down | Nov 9, 2023 | N/A |
| Jun 30, 2023 | -$0.62 | -$0.59 | -$0.69 - -$0.46 | -5.08% | Miss | -244.2% | 3 | 0 up, 0 down | Aug 10, 2023 | $334000 |
| Mar 31, 2023 | -$0.48 | -$0.58 | -$0.68 - -$0.35 | +17.24% | Beat | -785.7% | 3 | 0 up, 0 down | May 12, 2023 | $468000 |
| Dec 31, 2022 | -$0.57 | -$0.42 | -$0.43 - -$0.42 | -35.71% | Miss | N/A | 2 | 0 up, 0 down | Mar 30, 2023 | $6.46M |
| Sep 30, 2022 | $0.22 | -$0.52 | N/A | +142.31% | Beat | N/A | 3 | 0 up, 0 down | Nov 10, 2022 | $6.17M |
| Jun 30, 2022 | $0.43 | -$0.40 | N/A | +207.50% | Beat | N/A | N/A | 1 up, 0 down | Aug 9, 2022 | $17.06M |
| Mar 31, 2022 | $0.07 | -$0.31 | -$0.43 - -$0.26 | +122.58% | Beat | N/A | 4 | 0 up, 0 down | Jun 29, 2022 | $15.02M |
| Dec 31, 2021 | -$0.38 | -$0.58 | N/A | +34.48% | Beat | N/A | 4 | N/A | Mar 30, 2022 | N/A |
| Sep 30, 2021 | -$0.13 | -$0.30 | -$0.68 - -$0.30 | +56.67% | Beat | -103.9% | 4 | N/A | Nov 12, 2021 | $19000 |
| Jun 30, 2021 | -$0.64 | -$0.59 | -$1.15 - -$0.55 | -8.47% | Miss | N/A | 4 | N/A | Aug 12, 2021 | $35000 |
| Mar 31, 2021 | -$1.90 | -$2.11 | N/A | +9.95% | Beat | N/A | N/A | N/A | Jun 29, 2021 | $215000 |
| Dec 31, 2020 | -$92.90 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2020 | $354000 |
| Sep 30, 2020 | $3.32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 | $3.25M |
| Jun 30, 2020 | -$75.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2020 | $511000 |
| Mar 31, 2020 | -$80.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2020 | $705000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.52, after -$1.24 the year before. It was -$2.24 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.52 | N/A |
| Dec 31, 2024 | -$1.24 | N/A |
| Dec 31, 2023 | -$1.92 | -1380.0% |
| Dec 31, 2022 | $0.15 | N/A |
| Dec 31, 2021 | -$3.05 | N/A |
| Dec 31, 2020 | -$2.24 | N/A |
Frequently Asked Questions About BRNS
When is Barinthus Biotherapeutics's next earnings date?
Barinthus Biotherapeutics's next earnings report is expected for Mar 11, 2027.
Did BRNS beat earnings estimates last quarter?
Yes. Barinthus Biotherapeutics reported EPS of -$0.26 for the quarter ended Jun 30, 2026, above the -$0.28 estimate, a 7.14% surprise.
What EPS do analysts expect from BRNS next quarter?
The consensus EPS estimate for Barinthus Biotherapeutics for the quarter ended Sep 30, 2026 is -$0.26 from 2 analysts, with estimates from -$0.27 to -$0.25.
How often does BRNS beat earnings estimates?
Barinthus Biotherapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +13.46%.
BRNS pages: Overview, Earnings, Forecast, Financials, Competitors